GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Total Assets

Eckert & Ziegler SE (XTER:EUZ) Total Assets : €442.4 Mil (As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE Total Assets?

Eckert & Ziegler SE's Total Assets for the quarter that ended in Dec. 2024 was €442.4 Mil.

Warning Sign:

If a company builds assets at 14.2% a year, faster than its revenue growth rate of 10.9% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Eckert & Ziegler SE's average Total Assets Growth Rate was -12.70% per year. During the past 3 years, the average Total Assets Growth Rate was 8.60% per year. During the past 5 years, the average Total Assets Growth Rate was 14.20% per year. During the past 10 years, the average Total Assets Growth Rate was 9.30% per year.

During the past 13 years, Eckert & Ziegler SE's highest 3-Year average Total Assets Growth Rate was 25.40%. The lowest was -1.30%. And the median was 10.45%.

Total Assets is connected with ROA %. Eckert & Ziegler SE's annualized ROA % for the quarter that ended in Dec. 2024 was 8.58%. Total Assets is also linked to Revenue through Asset Turnover. Eckert & Ziegler SE's Asset Turnover for the quarter that ended in Dec. 2024 was 0.17.


Eckert & Ziegler SE Total Assets Historical Data

The historical data trend for Eckert & Ziegler SE's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Total Assets Chart

Eckert & Ziegler SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 289.44 347.73 407.46 439.36 442.40

Eckert & Ziegler SE Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 439.36 456.52 471.94 480.92 442.40

Eckert & Ziegler SE Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Eckert & Ziegler SE's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=225.213+217.183
=442.4

Eckert & Ziegler SE's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (Q: Dec. 2024 )+Total Liabilities (Q: Dec. 2024 )
=225.213+217.183
=442.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eckert & Ziegler SE  (XTER:EUZ) Total Assets Explanation

Total Assets is connected with ROA %.

Eckert & Ziegler SE's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %=Net Income (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=39.596/( (480.919+442.396)/ 2 )
=39.596/461.6575
=8.58 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Eckert & Ziegler SE's Asset Turnover for the quarter that ended in Dec. 2024 is

Asset Turnover
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=80.355/( (480.919+442.396)/ 2 )
=80.355/461.6575
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Eckert & Ziegler SE Total Assets Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.
Executives
Dr. Andreas Eckert Supervisory Board
Frank Perschmann Supervisory Board
Dr. Hakim Bouterfa Board of Directors
Prof. Dr. Wolfgang Maennig Supervisory Board
Dr. Harald Hasselmann Board of Directors

Eckert & Ziegler SE Headlines

No Headlines